Some corneal diseases can be treated with amniotic membrane transplantation

Jacob, Soosan; Agarwal, Amar
September 2012
Ocular Surgery News Europe;Sep2012, Vol. 23 Issue 8, p34
The article offers information on amniotic membrane transplantation as treatment for some corneal diseases. The advantages of amniotic membrane when used for ophthalmological purposes are discussed. Also explained are the ways by which amniotic membrane function in the treatment of persistent epithelial defects. Presented as well is an overview of how amniotic membrane is used in case of corneal or scleral melt.


Related Articles

  • Annular amniotic membrane transplantation as a host incorporated graft in the management of Brown-McLean syndrome. Angunawela, Romesh // Current Medical Literature: Ophthalmology;2013, Vol. 23 Issue 2, p58 

    The article discusses research that explored annular amniotic membrane transplantation as a host incorporated graft in the management of Brown-McLean syndrome. It references a study by H. T. Mai and R. Hamilton, published in a 2013 issue of the journal "Cornea." Findings show that an annular...

  • Oküler Yüzey Rekonstrüksiyonunda Amniyon Zarı Uygulamaları: Klinik Özellikler ve Tedavi Sonuçları. Cindarik, Derya; Yağmur, Meltem; Şekeroğlu, Hande Taylan; Erdem, Elif // Turkish Journal of Ophthalmology / Turk Oftalmoloji Dergisi;Jun2012, Vol. 42 Issue 3, p177 

    Purpose: To investigate the effectiveness of amniotic membrane transplantation in cases with corneal thinning, desmatocele and refractive corneal ulcer. Material and Method: Fifty-four eyes of 54 patients who were applied amniotic membrane transplantation for various ocular surface disease...

  • Editorial from the Corneal and External Disease Section Editor. Slomovic, Allan R.; Lichtinger, Alejandro // Vision Pan-America: The Pan-American Journal of Ophthalmology;Sep2014, Vol. 13 Issue 3, p65 

    The authors explains that the goal of this special issue of Vision Pan-America is to provide evidence-based clinical and surgical guidelines to the management of anterior segment diseases of the cornea.

  • Keratoprosthesis a viable option. Meszaros, Liz // Ophthalmology Times;3/15/2011, Vol. 36 Issue 6, p48 

    The article discusses the application of keratoprosthesis as a feasible therapeutic option of various patients having end-stage corneal diseases. Esen K. Akpek, associate professor of ophthalmology, notes that keratoprosthesis could be a viable option in patients with corneal blindness who are...

  • An Eye Under Attack. Chen, Ellin; Weissman, Barry A. // Review of Optometry;5/16/2009 Supplement, p37 

    The article offers advice on diagnosis and treatment plan for patients with corneal infiltrates. It presents a problem in which a 30-year old female soft contact lens wearer presents to a school's clinic to get consultation on her red eye. It cites the several factors in dealing with corneal...

  • OPHTHALMOLOGY. Alwitry, Amar // Pulse;5/10/2007, Vol. 67 Issue 18, p52 

    The article provides information related to corneal abrasion. Patients with corneal abrasion usually have staining on the cornea corresponding to the abrasion. Corneal abrasions are treated with antibiotic ointments. Prophylactic lubricant ointment every night will be recommended to stop the...

  • Eye rubbing pattern can give clues about keratoconus.  // Ocular Surgery News;7/10/2012, Vol. 30 Issue 13, p16 

    No abstract available.

  • Experts debate approaches to aberrated corneas. Wolkoff, Lauren; Mullin, David W.; Altersitz, Katrina; Boyle, Erin L. // Ocular Surgery News Europe/Asia-Pacific Edition;Aug2008, Vol. 19 Issue 8, p3 

    The article discusses a study on approaches to repairing corneal refractive complications which was presented at the 2008 World Ophthalmological Congress (WOC). According to expert Arthur Cheng, topography-guided treatment is generally a better approach to treating patients with irregular...

  • Phaco Technologies Help Clinical Outcomes.  // Review of Ophthalmology;Sep2004, Vol. 11 Issue 9, p74 

    Focuses on phacoemulsification technologies. Improvements in effective phaco time (EPT), average phaco power, percentage of clear corneas and 20/40 or better UCVA; Chemicals that have been found to cause intrastomal macroscopic crystalline deposits in the eyes through a compromised corneal...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics